We are live on ! Find out more
CIA

Capital Impact Advisors Portfolio holdings

AUM $247M
1-Year Est. Return 31.15%
This Fund
S&P 500
This Quarter Est. Return
+3.65%
1 Year Est. Return
+31.15%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$100M
AUM Growth
-$7.81M
Cap. Flow
-$11.3M
Cap. Flow %
-11.27%
Top 10 Hldgs %
11.69%
Holding
238
New
12
Increased
100
Reduced
117
Closed
1

Top Buys

Rank Stock Value
1
ARHS icon
Arhaus
ARHS
+$228K
2
AR icon
Antero Resources
AR
+$208K
3
MTDR icon
Matador Resources
MTDR
+$203K
4
SSTK icon
Shutterstock
SSTK
+$194K
5
EXE
Expand Energy Corp
EXE
+$188K

Top Sells

Rank Stock Value
1
ELF icon
e.l.f. Beauty
ELF
+$919K
2
GBT
Global Blood Therapeutics, Inc.
GBT
+$772K
3
CPRX
Catalyst Pharmaceutical
CPRX
+$637K
4
ENPH icon
Enphase Energy
ENPH
+$535K
5
META icon
Meta Platforms (Facebook)
META
+$528K

Sector Composition

Rank Sector Weight
1 Technology 29.49%
2 Healthcare 26.32%
3 Consumer Discretionary 12.34%
4 Industrials 8.94%
5 Financials 6.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FNKO icon
101
Funko
FNKO
$326M
$408K 0.41%
46,660
+2,929
+7% +$67.1K
RMD icon
102
ResMed
RMD
$30.6B
$406K 0.4%
1,860
-536
-22% -$122K
ZUO
103
DELISTED
Zuora, Inc.
ZUO
$405K 0.4%
51,653
+3,158
+7% +$27.2K
COHR icon
104
Coherent
COHR
$51.4B
$401K 0.4%
10,876
-2,492
-19% -$119K
ETSY icon
105
Etsy
ETSY
$7.75B
$399K 0.4%
3,988
-1,874
-32% -$191K
ANET icon
106
Arista Networks
ANET
$227B
$398K 0.4%
14,116
-3,236
-19% -$93.3K
KRYS icon
107
Krystal Biotech
KRYS
$10.1B
$395K 0.39%
5,150
+872
+20% +$63K
MC icon
108
Moelis & Co
MC
$4.97B
$393K 0.39%
9,100
+1,576
+21% +$66K
ESAB icon
109
ESAB
ESAB
$5.38B
$390K 0.39%
8,572
– –
TTEC icon
110
TTEC Holdings
TTEC
$121M
$388K 0.39%
8,329
-3,807
-31% -$226K
CACC icon
111
Credit Acceptance
CACC
$5.95B
$380K 0.38%
821
-76
-8% -$40.1K
JJSF icon
112
J&J Snack Foods
JJSF
$1.43B
$379K 0.38%
2,419
-1,399
-37% -$199K
ALGT icon
113
Allegiant Air
ALGT
$2.64B
$375K 0.37%
4,839
+909
+23% +$94K
GTLB icon
114
GitLab
GTLB
$5.83B
$375K 0.37%
9,139
+1,658
+22% +$96.8K
CTAS icon
115
Cintas
CTAS
$81.9B
$374K 0.37%
3,852
-4,380
-53% -$447K
CPAY icon
116
Corpay
CPAY
$25B
$371K 0.37%
2,107
-492
-19% -$105K
FORR icon
117
Forrester Research
FORR
$223M
$369K 0.37%
10,937
+1,316
+14% +$56.5K
ESI icon
118
Element Solutions
ESI
$8.95B
$360K 0.36%
18,932
– –
VIR icon
119
Vir Biotechnology
VIR
$1.46B
$360K 0.36%
13,196
+1,130
+9% +$28.7K
LHCG
120
DELISTED
LHC Group LLC
LHCG
$353K 0.35%
2,099
-1,032
-33% -$167K
KOD icon
121
Kodiak Sciences
KOD
$2.6B
$352K 0.35%
46,298
+3,884
+9% +$37.7K
VMW
122
DELISTED
VMware, Inc
VMW
$351K 0.35%
3,301
-713
-18% -$82.1K
CSV icon
123
Carriage Services
CSV
$641M
$348K 0.35%
14,052
-1,003
-7% -$37.5K
AAP icon
124
Advance Auto Parts
AAP
$3.35B
$342K 0.34%
2,258
-490
-18% -$89.5K
BBIO icon
125
BridgeBio Pharma
BBIO
$15.7B
$341K 0.34%
35,380
+5,371
+18% +$55.8K
3 4
5
6 7

Similar funds

AI
AXS Investments Port Chester, New York $248M AUM 15.95% 1-Year Est. Return
AB
ANB Bank Denver, Colorado $247M AUM 19.59% 1-Year Est. Return
PWS
Peloton Wealth Strategists Indianapolis, Indiana $247M AUM 13.57% 1-Year Est. Return
BFM
Blacksheep Fund Management Co. Dublin, Ireland $247M AUM 8.75% 1-Year Est. Return
IFPG
Intrepid Financial Planning Group Carmel, Indiana $248M AUM 19.02% 1-Year Est. Return
SCM
Segra Capital Management Palm Beach, Florida $248M AUM 65.61% 1-Year Est. Return
GWS
Greykasell Wealth Strategies Danville, California $248M AUM 22.08% 1-Year Est. Return
MC
Mount Capital London, United Kingdom $248M AUM 4.81% 1-Year Est. Return

Capital Impact Advisors's Q3 2022 Portfolio in Review

As of Q3 2022, Capital Impact Advisors held 238 positions worth $100M, down 7.2% from $108M the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Capital Impact Advisors withdrew a net $11.3M in Q3 2022, closing 1 position and reducing 117 holdings. Its most notable exit was Global Blood Therapeutics, Inc., an estimated $772K position sold in full.

By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Capital Impact Advisors opened a new position in Ginkgo Bioworks worth $118K.

  • Capital Impact Advisors's largest Q3 2022 buy was Ginkgo Bioworks: 1,374 shares worth $118K.
  • Capital Impact Advisors added most to Arhaus in Q3 2022, an estimated $228K increase.
  • Capital Impact Advisors's biggest Q3 2022 reduction was e.l.f. Beauty, cutting an estimated $919K.
  • Capital Impact Advisors fully exited Global Blood Therapeutics, Inc. in Q3 2022, selling an estimated $772K.
  • Capital Impact Advisors's ten largest holdings make up 12% of its $100M portfolio in Q3 2022.
  • Capital Impact Advisors opened 12 new positions and closed 1 in Q3 2022.
  • Capital Impact Advisors's portfolio value fell 7.2% quarter-over-quarter to $100M.

Based on Capital Impact Advisors's 13F filing for Q3 2022, filed 22 Nov 2022.